Last reviewed · How we verify
Placebo of DWJ1464 — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of DWJ1464 (Placebo of DWJ1464) — Daewoong Pharmaceutical Co. LTD.. A placebo formulation containing no active pharmaceutical ingredient, used as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of DWJ1464 TARGET | Placebo of DWJ1464 | Daewoong Pharmaceutical Co. LTD. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of DWJ1464 CI watch — RSS
- Placebo of DWJ1464 CI watch — Atom
- Placebo of DWJ1464 CI watch — JSON
- Placebo of DWJ1464 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of DWJ1464 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-dwj1464. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab